Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human EYA2 ELISA Kit (AC2614)
Cat.#: ASET-1203
Specifications
Description Human EYA2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human EYA2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 2.25 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 40-640 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1647 Mouse Wnt3a ELISA Kit (AC3058) Quantitative inquiry ASET-1805 Mouse Adenosine A1 Receptor ELISA Kit (AC3216) Quantitative inquiry ASET-2521 Human RKIP ELISA Kit (AC3932) Quantitative inquiry ASET-1795 Guinea Pig beta Nerve Growth Factor ELISA Kit (AC3206) Quantitative inquiry ASET-1674 Mouse Angiogenin ELISA Kit (AC3085) Quantitative inquiry ASET-1048 Human Profilin 1 ELISA Kit (AC2459) Quantitative inquiry ASET-1995 Human NRG4 ELISA Kit (AC3406) Quantitative inquiry ASET-1309 Human Plasminogen Activator ELISA Kit (AC2720) Quantitative inquiry ASET-2196 Human VMAT2 ELISA Kit (AC3607) Quantitative inquiry ASET-1083 Rat INHBC ELISA Kit (AC2494) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket